Skip to main content
. Author manuscript; available in PMC: 2015 Oct 3.
Published in final edited form as: Cancer Gene Ther. 2015 Apr 3;22(4):215–221. doi: 10.1038/cgt.2015.14

Table 2.

CD conversion activity (pmol/min/mg) of AdSSTR2-yCD in MCF-7 and T-47D cells infected at 10 or 100 pfu/cell (In Vitro) or in MCF-7 tumors directly injected with either 1 × 109 or 3 × 109 pfu (In Vivo). Conversion activity was not performed (NP) in T-47D tumors in vivo.

In Vitro In Vivo

10 pfu/cell 100 pfu/cell 1 × 109 pfu 3 × 109 pfu
MCF-7 62 ± 11 386 ± 27 193 ± 41 698 ± 81
T-47D 11 ± 1 214 ± 58 NP NP